Alan S. Go, MD

Articles by Alan S. Go, MD

Anticoagulation in Atrial Fibrillation: Impact of Mental Illness

BySusan K. Schmitt, PhD,Mintu P. Turakhia, MD, MAS,Ciaran S. Phibbs, PhD,Rudolf H. Moos, PhD,Dan Berlowitz, MD, MPH,Paul Heidenreich, MD, MS,Victor Y. Chiu, MD,Alan S. Go, MD,Sarah A. Friedman, MSPH,Claire T. Than, MPH,Susan M. Frayne, MD, MPH

November 30th 2015

Atrial fibrillation patients with mental health conditions are less likely to be eligible for warfarin receipt, and those who are eligible receive warfarin at lower rates.

Ethnic Differences in the Development of Albuminuria: The DISTANCE Study

ByAndy I. Choi, MD, MAS,Andrew J. Karter, PhD,Jennifer Y. Liu, MPH,Bessie A. Young, MD, MPH,Alan S. Go, MD,Dean Schillinger, MD

November 7th 2011

Despite uniform access to medical care, Filipinos, blacks, and Asians with diabetes developed albuminuria at higher rates than whites.

Mental Illness and Warfarin Use in Atrial Fibrillation

ByGraham A. Walker, MD,Paul A. Heidenreich, MD, MS,Ciaran S. Phibbs, PhD,Alan S. Go, MD,Victor Y. Chiu, BA,Susan K. Schmitt, PhD,Lakshmi Ananth, MS,Susan M. Frayne, MD, MPH

September 6th 2011

Atrial fibrillation patients with mental illness are less likely to receive warfarin anticoagulation; those who do receive warfarin have excess risk of over-anticoagulation.